Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura L Fernandes

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biometrical Journal. Biometrische Zeitschrift|August 8, 2015
Multivariate Markov models for the conditional probability of toxicity in phase II trialsLaura L Fernandes, Susan Murray, Jeremy M G Taylor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Reply to H. McLeod et alChana Weinstock, Laura L Fernandes, Marc Theoret, et al.
Blood Cancer Journal|September 1, 2021
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvementLaura L Fernandes, Jiaxi Zhou, Bindu Kanapuru, et al.
The Laryngoscope|August 7, 2012
Preoperative topical antimicrobial decolonization in head and neck surgeryAndrew G Shuman, Emily K Shuman, Samantha J Hauff, et al.
Clinical Lung Cancer|August 29, 2025
Treatment Patterns and Outcomes of Non-Small Cell Lung Cancer with High PD-L1 Expression using Real World EvidenceRosalyn Marar, Claire Bai, Eric Hansen, et al.
Cancer Treatment and Research Communications|July 21, 2023
Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational studyAnne Shah, Jon Apple, Andrew J Belli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted TherapyLei Nie, Eric H Rubin, Nitin Mehrotra, et al.
Future Oncology (London, England)|October 3, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma by line of therapyHelmneh M Sineshaw, Claire Bai, Enrico de Nigris, et al.
Blood|May 4, 2023
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trialsBindu Kanapuru, Laura L Fernandes, Andrea Baines, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancerKlaudia U Hunter, Laura L Fernandes, Karen A Vineberg, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biometrical Journal. Biometrische Zeitschrift|August 8, 2015
Multivariate Markov models for the conditional probability of toxicity in phase II trialsLaura L Fernandes, Susan Murray, Jeremy M G Taylor
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Reply to H. McLeod et alChana Weinstock, Laura L Fernandes, Marc Theoret, et al.
Blood Cancer Journal|September 1, 2021
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvementLaura L Fernandes, Jiaxi Zhou, Bindu Kanapuru, et al.
The Laryngoscope|August 7, 2012
Preoperative topical antimicrobial decolonization in head and neck surgeryAndrew G Shuman, Emily K Shuman, Samantha J Hauff, et al.
Clinical Lung Cancer|August 29, 2025
Treatment Patterns and Outcomes of Non-Small Cell Lung Cancer with High PD-L1 Expression using Real World EvidenceRosalyn Marar, Claire Bai, Eric Hansen, et al.
Cancer Treatment and Research Communications|July 21, 2023
Real-world study of disease-free survival & patient characteristics associated with disease-free survival in early-stage non-small cell lung cancer: A retrospective observational studyAnne Shah, Jon Apple, Andrew J Belli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted TherapyLei Nie, Eric H Rubin, Nitin Mehrotra, et al.
Future Oncology (London, England)|October 3, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with mantle cell lymphoma by line of therapyHelmneh M Sineshaw, Claire Bai, Enrico de Nigris, et al.
Blood|May 4, 2023
Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trialsBindu Kanapuru, Laura L Fernandes, Andrea Baines, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2013
Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancerKlaudia U Hunter, Laura L Fernandes, Karen A Vineberg, et al.
Pageof 3